abrdn Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$462M Buy
3,558,666
+370,943
+12% +$45.5M 1.56% 13
2017
Q1
$397M Sell
3,187,723
-125,148
-4% -$15M 1.31% 19
2016
Q4
$384M Sell
3,312,871
-411,068
-11% -$45.8M 1.33% 20
2016
Q3
$389M Sell
3,723,939
-366,417
-9% -$39.7M 1.6% 14
2016
Q2
$403M Sell
4,090,356
-35,581
-0.9% -$3.68M 1.82% 11
2016
Q1
$413M Buy
4,125,937
+316,474
+8% +$32.6M 1.88% 11
2015
Q4
$456M Sell
3,809,463
-109,605
-3% -$12.7M 1.93% 8
2015
Q3
$424M Sell
3,919,068
-37,210
-0.9% -$4.62M 1.82% 13
2015
Q2
$458M Sell
3,956,278
-130,359
-3% -$14.9M 1.94% 10
2015
Q1
$471M Buy
4,086,637
+575,191
+16% +$68.7M 1.93% 9
2014
Q4
$393M Sell
3,511,446
-993,395
-22% -$105M 1.55% 21
2014
Q3
$427M Buy
4,504,841
+611,803
+16% +$55.2M 1.62% 12
2014
Q2
$334M Buy
3,893,038
+2,088,308
+116% +$159M 1.49% 17
2014
Q1
$126M Sell
1,804,730
-32,798
-2% -$2.6M 0.6% 66
2013
Q4
$155M Buy
1,837,528
+460,892
+33% +$36.5M 0.82% 48
2013
Q3
$106M Buy
1,376,636
+826,146
+150% +$57.9M 0.61% 62
2013
Q2
$32.2M Buy
+550,490
New +$33.1M 0.2% 114

Other funds holding CELG

abrdn Investment Management's CELG Position: Q2 2017 in Review

abrdn Investment Management increased its Celgene Corp (CELG) stake by 12% in Q2 2017, buying an estimated $45.5M and bringing the position to 3,558,666 shares worth $462M. The position accounts for 1.56% of the portfolio, ranked #13.

abrdn Investment Management first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $471M in Q1 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • abrdn Investment Management held 3,558,666 shares of Celgene Corp worth $462M as of Q2 2017.
  • abrdn Investment Management bought 370,943 Celgene Corp shares in Q2 2017, an estimated $45.5M.
  • Celgene Corp made up 1.56% of abrdn Investment Management's portfolio in Q2 2017, its #13 holding.
  • abrdn Investment Management first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
  • abrdn Investment Management's Celgene Corp position peaked at $471M in Q1 2015.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.